About this episode

Sri Kosuri discusses small molecules designed to correct protein misfolding and mistrafficking related to various diseases.

Sri Kosuri, co-founder and CEO of Emeryville, Calif.-based Octant Bio, on small molecules designed to correct protein misfolding and mistrafficking at the root of many diseases.

More episodes of The Long Run with Luke Timmerman

• Ep205: Heather Turner on a Schizophrenia Drug Patients Can Stick With · July 14, 2026 · 1h 8m
• Ep204: Troy Wilson on Precision Cancer Drugs and Combos · June 30, 2026 · 1h 7m

Explore listener stats, chart rankings, contacts and more on the The Long Run with Luke Timmerman podcast page.